Familial Resemblance in Low-Density Lipoprotein Cholesterol Response to Statins in the Danish Population

被引:0
|
作者
Corn, Giulia [1 ]
Lund, Marie [1 ,2 ,3 ]
Hlatky, Mark A. [4 ,5 ]
Wohlfahrt, Jan [1 ]
Melbye, Mads [3 ,6 ,7 ,8 ]
机构
[1] Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark
[2] Copenhagen Univ Hosp Bispebjerg, Dept Clin Pharmacol, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[4] Stanford Univ, Sch Med, Dept Hlth Policy, Stanford, CA 94305 USA
[5] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[6] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
[7] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth, Oslo, Norway
[8] Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway
来源
关键词
familial environment; genetic; inheritance; LDL-C; statin response; METAANALYSIS;
D O I
10.1161/JAHA.121.025465
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Change in low-density lipoprotein cholesterol (LDL-C) level after statin initiation varies widely among individuals, and in part may be because of factors shared by family members. Methods and Results We used the Danish national registers to identify 89 006 individuals who initiated statins between 2008 and 2018 and had LDL-C measured immediately before and after the start of treatment. Among these, we identified 5148 first-degree relatives and 3198 spouses. We decomposed the variation in attained LDL-C level after statin initiation by applying a mixed-effect model with 5 variance components (inter-family and inter-individual variance in pre-statin LDL-C level, inter-family and inter-individual variance in statin response, and residual variance). Results were presented as a percentage of the total variance explained by the different variance components. We found that half of the variation in attained LDL-C level after statin initiation consisted of variance in statin response, approximately one third of variance in pre-statin LDL-C level, and the remaining 10% to 15% of residual variance. While the inter-individual variance in statin response accounted for almost half of the LDL-C variation in both cohorts, the inter-family variance in statin response accounted for 3.3% among first-degree relatives and for 6.0% among spouses. Conclusions Individual factors account for most of the variation in LDL-C level after statin initiation; factors affecting statin response common within spouses and first-degree relatives account for a similar share of variation. These results suggest a modest influence of shared genetics and shared familial environment on statin response.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] Association Between Age and Low-Density Lipoprotein Cholesterol Response to Statins A Danish Nationwide Cohort Study
    Corn, Giulia
    Melbye, Mads
    Hlatky, Mark A.
    Wohlfahrt, Jan
    Lund, Marie
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (08) : 1017 - +
  • [2] Statins and low-density lipoprotein cholesterol levels
    Cohen, JS
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01): : 74 - 75
  • [3] The association between age and low-density lipoprotein cholesterol response statins
    Corn, Giulia
    Melbye, Mads
    Hlatky, Mark A.
    Wohlfahrt, Jan
    Lund, Marie
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 390 - 391
  • [4] Statins and low-density lipoprotein cholesterol levels - Reply
    Frolkis, JP
    Pearce, GL
    Sprecher, DL
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01): : 75 - 76
  • [5] Statins, low-density lipoprotein cholesterol, and risk of cancer
    Alsheikh-Ali, Alawi A.
    Trikalinos, Thomas A.
    Kent, David M.
    Karas, Richard H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (14) : 1141 - 1147
  • [6] Means and ends of statins and low-density lipoprotein cholesterol lowering
    LaRosa, John C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (05) : 419 - 420
  • [7] A Comparison of the Effectiveness of Statins in Reducing Total Cholesterol and Low-Density Lipoprotein Cholesterol
    But, Anna
    Suvisaari, Janne
    Suvisaari, Jaana
    Niskanen, Leo
    Haukka, Jari
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 111 - 112
  • [8] Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol measurement in Familial Dysbetalipoproteinemia
    Heidemann, Britt E.
    Koopal, Charlotte
    Lennep, Jeanine E. Roeters van
    Stroes, Erik S.
    Riksen, Niels P.
    Mulder, Monique T.
    van Vark - van der Zee, Leonie C.
    Blackhurst, Dee M.
    Visseren, Frank L. J.
    Marais, A. David
    [J]. CLINICA CHIMICA ACTA, 2023, 539 : 114 - 121
  • [9] Low-density lipoprotein cholesterol response to statins according to comorbidities and co-medications: A population-based study
    Corn, Giulia
    Lund, Marie
    Andersson, Niklas W.
    Dohlmann, Tine L.
    Hlatky, Mark A.
    Wohlfahrt, Jan
    Melbye, Mads
    [J]. AMERICAN HEART JOURNAL, 2024, 274 : 102 - 112
  • [10] Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition
    Marcusa, Daniel P.
    Giugliano, Robert P.
    Park, Jeong-Gun
    de Lemos, James A.
    Cannon, Christopher P.
    Sabatine, Marc S.
    [J]. JAMA CARDIOLOGY, 2021, 6 (05) : 582 - 586